T1	Participants 108 146	patients with advanced cervical cancer
T2	Participants 299 334	locally advanced cervical carcinoma
T3	Participants 386 472	1 women with FIGO stage IB2-IVA cervical cancer or with postsurgical pelvic recurrence
T4	Participants 1517 1549	advanced carcinoma of the cervix
